R&D Systems Recombinant Human VSIG2 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9815VS100
DescriptionThe Recombinant Human VSIG2 Fc Chimera Protein is derived from NS0. The Recombinant Human VSIG2 Fc Chimera Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2 μm filtered solution in PBS.|
|12 months from date of receipt, ≤ -20°C as supplied; 1 month, 2 to 8°C under sterile conditions after reconstitution; 3 months, ≤ -20°C under sterile conditions after reconstitution.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Reconstitute at 500 μg/mL in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|Mouse myeloma cell line, NS0-derived human VSIG2 protein|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok